3 Penny Stocks to Watch on July 29, 2025: AEye Inc., Incannex Healthcare, and SMX Public Limited

Three penny stocks to watch on July 29, 2025, are AEye Inc., Incannex Healthcare, and SMX Public Limited, based on TipRanks' Penny Stock Screener tool. AEye develops advanced lidar systems for autonomous vehicles and ADAS solutions, while Incannex Healthcare is a clinical-stage biopharmaceutical company developing treatments for chronic conditions. SMX offers authentication and tracking solutions for product authenticity and supply chain traceability. These stocks have high dollar volume and have shown significant price changes recently.

Three penny stocks have caught the attention of investors and financial professionals alike, according to TipRanks' Penny Stock Screener tool. These stocks, AEye Inc. (NASDAQ: LIDR), Incannex Healthcare Inc. (NASDAQ: IXHL), and SMX Public Limited, have shown significant price changes recently and have high dollar volume. Here's an overview of each:

AEye Inc. (NASDAQ: LIDR)
AEye Inc., a pioneer in high-performance lidar, has positioned itself at the intersection of innovation and industrialization through its recent integration of the Apollo lidar sensor into NVIDIA's DRIVE AGX platform [1]. This strategic move validates AEye's vision to redefine mobility by leveraging Apollo's 1-kilometer detection range and software-defined architecture. While the company faces financial turbulence, the long-term strategic value of its lidar technology remains promising. The integration with NVIDIA's ecosystem, which includes major OEMs like Tesla, BMW, and Toyota, could help AEye bypass traditional market entry barriers.

Incannex Healthcare Inc. (NASDAQ: IXHL)
Incannex Healthcare Inc. has seen its stock price rise by 34.63% after promising FDA designations boosted investor confidence [2]. The appointment of a celebrated sleep medicine expert, Dr. Douglas B. Kirsch, to its Clinical Advisory Board further enhances the company's credibility. Incannex is developing treatments for chronic conditions, with a focus on Obstructive Sleep Apnea (OSA). The company's financials show a modest revenue of $12,000 but a high price-to-sales ratio of 2,060.37. While profitability remains a challenge, the company's positive cash flow position and strategic moves indicate potential for high growth. Investors should keep an eye on the upcoming Phase 2 trial results and Dr. Kirsch's insights.

SMX Public Limited
SMX Public Limited offers authentication and tracking solutions for product authenticity and supply chain traceability. The company's recent price changes and high dollar volume make it an attractive option for investors looking for growth opportunities in the supply chain management sector. While specific financial details for SMX were not provided in the reference materials, its focus on innovative solutions for product authenticity and supply chain traceability positions it as a key player in the industry.

For investors and financial professionals, these three penny stocks present unique opportunities and challenges. AEye Inc. offers exposure to the autonomous vehicle revolution, while Incannex Healthcare Inc. focuses on innovative treatments for chronic conditions. SMX Public Limited provides a chance to invest in supply chain management solutions. As always, it is crucial to conduct thorough research and consider both the risks and potential rewards before making investment decisions.

References:
[1] https://www.ainvest.com/news/aeye-strategic-integration-nvidia-catalyst-long-term-growth-autonomous-mobility-2507/
[2] https://stockstotrade.com/news/incannex-healthcare-inc-ixhl-news-2025_07_24/